FIPB approves Sun Pharma issuing shares to non-resident investors


(Photo Courtesy:

With reference to earlier announcement dated November 24, 2014 regarding updates on Scheme of Arrangement, Sun Pharmaceutical has informed further to Bombay Stock Exchange (BSE) that Foreign Investment Promotion Board (FIPB) has approved its proposal for issuing its equity shares to the non-resident investors of Ranbaxy Laboratories pursuant to the merger of Ranbaxy Laboratories into Sun Pharmaceutical Industries through the scheme of arrangement between Ranbaxy Laboratories and Sun Pharmaceutical Industries.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email